NCT03810820 - Remote ECG Monitoring of TAVI Patients | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

June 20, 2018

Primary Completion Date

July 30, 2020

Study Completion Date

July 30, 2021

Conditions

Cardiac Valve DiseaseAortic Valve Stenosis

Interventions

DEVICE

mobile Cardiac Arrhythmia Diagnostics Service (m-CARDS)

A wearable cardiac monitoring device is provided to patients pre- and post-TAVI. The monitor transmits cardiac data in real time to the m-CARDs team. Cardiac abnormalities are reported to the clinical team who then assess the abnormality and intervene as clinically necessary.

Trial Locations (1)

L8L 2X2

Hamilton Health Sciences Corporation - Hamilton General Hospital, Hamilton